Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 07. Juni 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8938  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178757  
   
Diagnostic value of PSA-based markers in prostate cancer: a retrospective analysis stratified by body mass index.
BMC Urol
Yang T, Zhang Q, Liu Z, Tian J, Hu X, Lv Z.
PMID: 42251295 [PubMed - as supplied by publisher]


Multimodal Artificial Intelligence Prediction of Abiraterone Efficacy in Two STAMPEDE Phase 3 Trials of Non-Metastatic Very High-Risk Prostate Cancer.
Ann Oncol
Parker CTA, Huang HC, Grist E, Mendes L, Yamashita R, Croucher D, Sachdeva A, Murphy L, Liu VYT, Vidal SS, Todorovic T, Lall S, Goncalves M, Thakali S, Wingate A, Zakka L, Wetterskog D, Nowakowska K, Amos CL, STAMPEDE Collaborators, Berney DM, Tran PT, Spratt DE, Sydes MR, Brown LC, Zhao SG, Nguyen P, Clarke NW, Sweeney CJ, Stewart EL, Parmar MKB, Esteva A, James ND, Attard G.
PMID: 42250604 [PubMed - as supplied by publisher]


Glycovariant-based diagnosis of bladder cancer using urinary mucin 1 and carcinoembryonic antigen.
J Pharm Biomed Anal
Syed P, Islam MK, Kekki H, Terävä J, Lamminmäki U, Boström PJ, Leivo J, Gidwani K.
PMID: 42250336 [PubMed - as supplied by publisher]


Identification and external validation of a prognostic signature based on bone morphogenetic protein-related mRNAs for kidney renal clear cell carcinoma.
Discov Oncol
Zhou Y, Hu Z, Xie L, Zhang S, Huang Q, Zhang N, Liu Y, Zhang W, Wang K.
PMID: 42250062 [PubMed - as supplied by publisher]


Microstructure imaging of prostate cancer by diffusion MRI.
MAGMA
Szczepankiewicz F, Panagiotaki E, Molendowska M, Sandeman K, Palombo M, Wu D.
PMID: 42250048 [PubMed - as supplied by publisher]


Impact of CKD on perioperative outcomes following TURBT: a national NSQIP analysis.
World J Urol
Touma Sawaya R, Nasrallah O, El Hajj A, Abdessater M.
PMID: 42249173 [PubMed - indexed for MEDLINE]


Enhancing foundation model transfer for prostate cancer detection with patch-level contrastive learning.
NPJ Digit Med
Lee JH, Li CX, Jahanandish H, Bhattacharya I, Vesal S, Song Y, Zhang L, Sang S, Choi MH, Soerensen SJC, Zhou SR, Sommer ER, Seibert TM, Fan R, Ghanouni P, Sonn GA, Rusu M.
PMID: 42249085 [PubMed - as supplied by publisher]


Epigenetic modulation of prostate cancer disparities in men with African ancestry.
Nat Rev Urol
Craddock J, Hayes VM.
PMID: 42249067 [PubMed - as supplied by publisher]


Rates of adjacent organ invasion in non-metastatic renal cell carcinoma: a population-based study.
Eur J Surg Oncol
Filzmayer M, Quarta L, Petix M, Orlandi F, Goyal JA, Briganti A, Carmignani L, Micali S, Shariat SF, Kosiba M, Humke C, Saad F, Chun FK, Karakiewicz PI.
PMID: 42247963 [PubMed - as supplied by publisher]


Artificial intelligence in prostate cancer imaging: A mini-review of current applications and future directions.
Urol Oncol
Ergül MA, Sabur V.
PMID: 42247882 [PubMed - as supplied by publisher]


Mixture cure model analysis of event-free survival in the NIAGARA Trial: Quantifying the cure fraction benefit of perioperative durvalumab in muscle-invasive bladder cancer.
Urol Oncol
Yajima S, Yoshida S, Chen W, Fukushima H, Tanaka H, Sato H, Hirakawa A, Masuda H, Fujii Y.
PMID: 42247881 [PubMed - as supplied by publisher]


Real-world outcomes of definitive chemoradiotherapy for bladder cancer: a multi-institutional retrospective study in Japan.
Jpn J Clin Oncol
Sugahara D, Murofushi KN, Yamashita H, Ogo E, Kikuchi K, Saito AI, Komiyama T, Imano N, Igarashi A, Ohno S, Onishi H.
PMID: 42247594 [PubMed - as supplied by publisher]


Integrative Biology Approaches Uncover Plasticizers' Pro-Carcinogenic Role in Prostate Cancer via Molecular Docking and Network Toxicology.
OMICS
Huang J, Huang Y, Huang Y, Lin Z, Liao L, Yang L, Chen S.
PMID: 42247313 [PubMed - as supplied by publisher]


Precise zonal diagnosis: multi-b-value DWI model reveals differential predictors of clinically significant prostate cancer in peripheral and transition zones.
Insights Imaging
He K, Chen Y, Kang Z, Li S, Gao M, Yin T, Chen W, Darwish O, Li Z.
PMID: 42247047 [PubMed]


Costing the national clinical guidelines for prostate cancer control and management in South Africa: Public sector perspective.
S Afr Med J
Thsehla E, Khoza M, Boachie MK, Mdewa W, Goldstein S, Somaroo H, Hofman KJ.
PMID: 42246791 [PubMed - indexed for MEDLINE]


Toward the genetic landscape of prostate cancer in India: insights from whole-exome and low-pass whole-genome sequencing of formalin-fixed paraffin-embedded tumor tissues.
Front Syst Biol
Biswas S, Rajarathinam B, Khilwani B, Jalendra G, Sharma D, Vijavargiya M, Aradhya R, Ansari AS, Shukla N, Chaubey G, Lohiya NK, Suravajhala P, CA Prostate Consortium of India (CAPCI).
PMID: 42246034 [PubMed]


Cross-population metabolome-wide Mendelian randomization study of prostate cancer risk.
Res Sq
Fuller H, Rohde R, Highland HM, Haessler J, Wu L, Graff M, Platz EA, Alkis T, Yu B, Boerwinkle E, Grove M, Kooperberg C, Peters U, North KE, Conti DV, Haiman CA, Young KL, Graff RE, Darst BF.
PMID: 42245788 [PubMed]


Detection of microplastics in bladder wash fluid obtained after cystoscopy in patients diagnosed with bladder cancer.
Front Public Health
Y, Ataman M, Tuna A.
PMID: 42245347 [PubMed - indexed for MEDLINE]


Validation, implementation, and impact of an AI model in routine practice for pathologic diagnosis of prostate cancer in an academic medical center.
J Pathol Inform
Udoh AI, Eyzaguirre E, Muthukumarana V, Thaker HM.
PMID: 42245328 [PubMed]


Therapeutic pressure drives the evolution of a protective ecotype characterized by AR-loss-induced senescence in prostate cancer.
Theranostics
He L, Jiang J, Liu S, Song H, Lu T, Hu Z, Li Y, Zhu H, Zhou Y, Li Z, Yang F, Zhang K, Zhang R, Wu T, Gan K, Zhao B, Zhang J, Si D, Zhang R, Shi C, Wen W, Han D, Xu C, Qin W.
PMID: 42244988 [PubMed - in process]


   
   Artikel 1 - 20 / 178757    Seite 1 von 8938  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1